Yang Y[au] - Search Results

Year	Number of Results
1946	1
1955	1
1956	1
1957	4
1958	1
1959	3
1960	2
1961	4
1962	7
1963	5
1964	10
1965	9
1966	5
1967	3
1968	8
1969	3
1970	1
1971	5
1972	6
1973	6
1974	6
1975	7
1976	11
1977	6
1978	6
1979	20
1980	24
1981	19
1982	25
1983	25
1984	30
1985	40
1986	55
1987	69
1988	90
1989	85
1990	91
1991	95
1992	115
1993	135
1994	169
1995	175
1996	234
1997	243
1998	263
1999	271
2000	356
2001	412
2002	464
2003	672
2004	797
2005	1032
2006	1241
2007	1385
2008	1587
2009	1869
2010	2247
2011	2688
2012	3187
2013	3804
2014	4380
2015	5127
2016	5423
2017	6065
2018	7009
2019	7811
2020	9615
2021	10900
2022	13066
2023	13027
2024	15405
2025	2361

1

Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway.

Li Y, Chen H, Yang Q, Wan L, Zhao J, Wu Y, Wang J, Yang Y, Niu M, Liu H, Liu J, Yang H, Wan S, Wang Y, Bao D. Li Y, et al. Among authors: yang y. J Exp Clin Cancer Res. 2022 Feb 24;41(1):76. doi: 10.1186/s13046-022-02262-z. J Exp Clin Cancer Res. 2022. PMID: 35209954 Free PMC article.

2

Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway.

Wang JZ, Zhu H, You P, Liu H, Wang WK, Fan X, Yang Y, Xu K, Zhu Y, Li Q, Wu P, Peng C, Wong CC, Li K, Shi Y, Zhang N, Wang X, Zeng R, Huang Y, Yang L, Wang Z, Hui J. Wang JZ, et al. Among authors: yang y. J Clin Invest. 2022 Apr 15;132(8):e146536. doi: 10.1172/JCI146536. J Clin Invest. 2022. PMID: 35239512 Free PMC article.

3

System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.

Wang X, Zhou T, Chen X, Wang Y, Ding Y, Tu H, Gao S, Wang H, Tang X, Yang Y. Wang X, et al. Among authors: yang y. J Immunother Cancer. 2022 Mar;10(3):e004414. doi: 10.1136/jitc-2021-004414. J Immunother Cancer. 2022. PMID: 35246476 Free PMC article.

4

Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.

Koblish HK, Wu L, Wang LS, Liu PCC, Wynn R, Rios-Doria J, Spitz S, Liu H, Volgina A, Zolotarjova N, Kapilashrami K, Behshad E, Covington M, Yang YO, Li J, Diamond S, Soloviev M, O'Hayer K, Rubin S, Kanellopoulou C, Yang G, Rupar M, DiMatteo D, Lin L, Stevens C, Zhang Y, Thekkat P, Geschwindt R, Marando C, Yeleswaram S, Jackson J, Scherle P, Huber R, Yao W, Hollis G. Koblish HK, et al. Among authors: yang yo. Cancer Discov. 2022 Jun 2;12(6):1482-1499. doi: 10.1158/2159-8290.CD-21-1156. Cancer Discov. 2022. PMID: 35254416 Free PMC article. Clinical Trial.

5

Cancer therapy-related interstitial lung disease.

Zhou C, Deng H, Yang Y, Wang F, Lin X, Liu M, Xie X, Luan T, Zhong N. Zhou C, et al. Among authors: yang y. Chin Med J (Engl). 2025 Feb 5;138(3):264-277. doi: 10.1097/CM9.0000000000003149. Epub 2024 Oct 11. Chin Med J (Engl). 2025. PMID: 39402974 Free PMC article. Review.

6

Repurposing Drugs for Cognition in Schizophrenia.

Yang YS, Marder SR, Green MF. Yang YS, et al. Clin Pharmacol Ther. 2017 Feb;101(2):191-193. doi: 10.1002/cpt.529. Epub 2016 Nov 24. Clin Pharmacol Ther. 2017. PMID: 27706797 Review.

7

SERAC1 is a component of the mitochondrial serine transporter complex required for the maintenance of mitochondrial DNA.

Fang H, Xie A, Du M, Li X, Yang K, Fu Y, Yuan X, Fan R, Yu W, Zhou Z, Sang T, Nie K, Li J, Zhao Q, Chen Z, Yang Y, Hong C, Lyu J. Fang H, et al. Among authors: yang y. Sci Transl Med. 2022 Mar 2;14(634):eabl6992. doi: 10.1126/scitranslmed.abl6992. Epub 2022 Mar 2. Sci Transl Med. 2022. PMID: 35235340

8

HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis.

Song Z, Zhang Y, Luo W, Sun C, Lv C, Wang S, He Q, Xu R, Bai Z, Chang X, Yang Y. Song Z, et al. Among authors: yang y. Curr Cancer Drug Targets. 2025;25(2):144-158. doi: 10.2174/0115680096279597240219055135. Curr Cancer Drug Targets. 2025. PMID: 38465433

9

Shell buckling for programmable metafluids.

Djellouli A, Van Raemdonck B, Wang Y, Yang Y, Caillaud A, Weitz D, Rubinstein S, Gorissen B, Bertoldi K. Djellouli A, et al. Among authors: yang y. Nature. 2024 Apr;628(8008):545-550. doi: 10.1038/s41586-024-07163-z. Epub 2024 Apr 3. Nature. 2024. PMID: 38570688

10

Topical ocular drug delivery systems: Innovations for an unmet need.

Yang Y, Lockwood A. Yang Y, et al. Exp Eye Res. 2022 May;218:109006. doi: 10.1016/j.exer.2022.109006. Epub 2022 Mar 4. Exp Eye Res. 2022. PMID: 35248559 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111,021 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111,021 results

Results by year